IL105143A - מונוהידרטים גבישיים עמידים של אנדו-2,3-דיהידרו- n)-8-מתיל-8-אזאביציקלו]3.2.1[ אוקט-3-איל(-2- אוקסו- h1- בנזאימידאז - Google Patents

מונוהידרטים גבישיים עמידים של אנדו-2,3-דיהידרו- n)-8-מתיל-8-אזאביציקלו]3.2.1[ אוקט-3-איל(-2- אוקסו- h1- בנזאימידאז

Info

Publication number
IL105143A
IL105143A IL10514393A IL10514393A IL105143A IL 105143 A IL105143 A IL 105143A IL 10514393 A IL10514393 A IL 10514393A IL 10514393 A IL10514393 A IL 10514393A IL 105143 A IL105143 A IL 105143A
Authority
IL
Israel
Prior art keywords
compound
azabicyclo
dihydro
oxo
endo
Prior art date
Application number
IL10514393A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI920723A external-priority patent/IT1254565B/it
Priority claimed from ITMI920720A external-priority patent/IT1254562B/it
Application filed by Boehringer Ingelheim Italia filed Critical Boehringer Ingelheim Italia
Publication of IL105143A publication Critical patent/IL105143A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL10514393A 1992-03-26 1993-03-24 מונוהידרטים גבישיים עמידים של אנדו-2,3-דיהידרו- n)-8-מתיל-8-אזאביציקלו]3.2.1[ אוקט-3-איל(-2- אוקסו- h1- בנזאימידאז IL105143A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI920723A IT1254565B (it) 1992-03-26 1992-03-26 Forma cristallina dell'endo-2,3-diidro-n-(8 metil-8-azabiciclo-(3.2.1) ott-3-il)-2-oxo-1h-benzimidazolo-1-carbossamide cloridrato
ITMI920720A IT1254562B (it) 1992-03-26 1992-03-26 Forma cristallina dell'endo-3-etil-2,3-diidro-n-(8-metil-8-azabiciclo (3.2.1) ott-3-il)- 2-oxo-1h-benzimidazolo-1-carbossamide cloridrato

Publications (1)

Publication Number Publication Date
IL105143A true IL105143A (he) 1996-10-16

Family

ID=26330860

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10514393A IL105143A (he) 1992-03-26 1993-03-24 מונוהידרטים גבישיים עמידים של אנדו-2,3-דיהידרו- n)-8-מתיל-8-אזאביציקלו]3.2.1[ אוקט-3-איל(-2- אוקסו- h1- בנזאימידאז

Country Status (28)

Country Link
US (1) US5468758A (he)
EP (1) EP0567767B1 (he)
JP (1) JP3279707B2 (he)
AT (1) ATE169016T1 (he)
AU (1) AU654082B2 (he)
BR (1) BR1100564A (he)
CA (1) CA2092510C (he)
CZ (1) CZ286590B6 (he)
DE (1) DE69319955T2 (he)
DK (1) DK0567767T3 (he)
ES (1) ES2118846T3 (he)
FI (1) FI113472B (he)
HK (1) HK1010719A1 (he)
HR (1) HRP930479B1 (he)
HU (2) HU211075B (he)
IL (1) IL105143A (he)
MX (1) MX9301668A (he)
NO (1) NO300975B1 (he)
NZ (1) NZ247234A (he)
PH (1) PH30413A (he)
PL (1) PL172890B1 (he)
RU (1) RU2125054C1 (he)
SG (1) SG43225A1 (he)
SI (1) SI9300150B (he)
SK (1) SK280555B6 (he)
TW (1) TW385310B (he)
UA (1) UA37179C2 (he)
UY (2) UY25938A1 (he)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2240637T3 (es) 1996-01-17 2005-10-16 Ricoh Company, Ltd. Aparato de fijacion para un aparato de formacion de imagenes.
JPH1039679A (ja) * 1996-05-24 1998-02-13 Ricoh Co Ltd 定着装置
PE20001420A1 (es) 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
US8697722B2 (en) * 2007-11-02 2014-04-15 Sri International Nicotinic acetylcholine receptor modulators
US9062042B2 (en) * 2010-01-11 2015-06-23 Astraea Therapeutics, Llc Nicotinic acetylcholine receptor modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223511A (en) * 1987-09-23 1993-06-29 Boehringer Ingelheim Italia S.P.A. Benzimidazoline-2-oxo-1-carboxylic acid compounds useful as 5-HT receptor antagonists
GB9121835D0 (en) * 1991-10-15 1991-11-27 Smithkline Beecham Plc Pharmaceuticals
PH31171A (en) * 1992-02-04 1998-03-20 Esai Co Ltd Aminobenzonic acid derivatives useful for treatinggastrointestinal conditions.

Also Published As

Publication number Publication date
PL172890B1 (pl) 1997-12-31
DE69319955D1 (de) 1998-09-03
HK1010719A1 (en) 1999-06-25
JP3279707B2 (ja) 2002-04-30
HU211075B (en) 1995-10-30
SG43225A1 (en) 1997-10-17
US5468758A (en) 1995-11-21
CA2092510C (en) 2004-02-03
SI9300150B (sl) 1998-06-30
HUT63846A (en) 1993-10-28
DK0567767T3 (da) 1999-02-01
CZ44393A3 (en) 1994-01-19
AU3541393A (en) 1993-09-30
CA2092510A1 (en) 1993-09-27
CZ286590B6 (cs) 2000-05-17
SK22693A3 (en) 1993-11-10
ES2118846T3 (es) 1998-10-01
HRP930479B1 (en) 1999-10-31
BR1100564A (pt) 2000-06-27
NO931112L (no) 1993-09-27
JPH0673053A (ja) 1994-03-15
NO300975B1 (no) 1997-08-25
UA37179C2 (uk) 2001-05-15
NO931112D0 (no) 1993-03-25
SK280555B6 (sk) 2000-03-13
HRP930479A2 (en) 1995-02-28
PL298263A1 (en) 1994-01-10
EP0567767B1 (en) 1998-07-29
FI113472B (fi) 2004-04-30
ATE169016T1 (de) 1998-08-15
HU211131A9 (en) 1995-10-30
DE69319955T2 (de) 1999-04-15
MX9301668A (es) 1993-09-01
UY25939A1 (es) 2001-08-27
UY25938A1 (es) 2000-09-29
SI9300150A (en) 1993-09-30
RU2125054C1 (ru) 1999-01-20
FI931329A (fi) 1993-09-27
NZ247234A (en) 1995-12-21
PH30413A (en) 1997-05-09
EP0567767A1 (en) 1993-11-03
FI931329A0 (fi) 1993-03-25
HU9300868D0 (en) 1993-06-28
AU654082B2 (en) 1994-10-20
TW385310B (en) 2000-03-21

Similar Documents

Publication Publication Date Title
ES2343220T3 (es) Medicamento a base de aripiprazol (cristal d) que tiene higroscopicidad reducida y su procedimiento de preparacion.
US9162985B2 (en) Salts and solvates of a tetrahydroisoquinoline derivative
EP3183253B1 (en) Salt of (r)-3-(4-(7h-pyrrolo [2,3-d]pyrimidin-4-yl)-lh-pyrazol-l-yl)-3-cyclopentylpropanenitrile with benzenesulfonic acid
TW202110811A (zh) Btk抑制劑之結晶形狀
JP2012523395A (ja) サクサグリプチンの結晶形態
JP2017193561A (ja) ３−（４−ニトロ−１−オキソイソインドリン−２−イル）ピペリジン−２，６−ジオンの固体形態
IL105143A (he) מונוהידרטים גבישיים עמידים של אנדו-2,3-דיהידרו- n)-8-מתיל-8-אזאביציקלו]3.2.1[ אוקט-3-איל(-2- אוקסו- h1- בנזאימידאז
JP2013529224A (ja) 結晶性エザチオスタット塩酸塩非溶媒和物
RU2193560C2 (ru) Новая соль
US8361971B2 (en) Tablet formulation of ezatiostat
KR100256148B1 (ko) 결정 형태의 엔도-2,3-디하이드로-n-(8-메틸-8-아자비사이클로(3.2.1)옥트-3-일)-2-옥트-1h-벤즈이미다졸-1-카복스아미드 하이드로클로라이드 1수화물 및 엔도-3-에틸-2,3-디하이드로-n-(8-메틸-8-아자비시클로(3.2.1)옥트-3-일)-2옥소-1h-벤즈이미다졸-1-카복스아미드 하이드로클로라이드 1수화물
ES2848436T3 (es) Cristal de derivado de 5-hidroxi-4-(trifluorometil)pirazolopiridina
EA045430B1 (ru) Композиция, содержащая гидрат безилата левамлодипина, и способ ее получения
AU2003243615A1 (en) Novel crystalline forms of gatifloxacin
RU2178789C2 (ru) Новые полиморфные формы дигидрохлорида лесопитрона и их гидратные формы, способы получения и композиции на их основе
WO2019053491A1 (en) CRYSTALLINE BENIDIPINE HCL SOLID FORMS AND PROCESSES FOR PREPARING THE SAME

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
RH Patent void
KB Patent renewed
EXP Patent expired